Hedge Fund-Mimicking ETF Launched by Goldman Sachs

Page 2 of 2

Among the most popular companies in Goldman Sachs’ Very Important Positions index portfolios are Facebook, Inc (NASDAQ: FB), Charter Communications, Inc. (NASDAQ:CHTR) Amazon.com, Inc. (NASDAQ: AMZN) and Allergan plc Ordinary Shares (NYSE: AGN). Let’s see how hedge funds tracked by Insider Monkey are positioned in each of these companies.

Facebook Inc (NASDAQ:FB)

Out of the 749 funds in our database which filed 13Fs for the June quarter, 148 were long Facebook Inc (NASDAQ:FB) at the end of the second quarter, down from 164 funds a quarter earlier. Nonetheless, it ranked as the second-most popular stock among them, so it’s unsurprising that it also made Goldman’s list. At the end of the third quarter, John Armitage’s Egerton Capital held 4.49 million shares of the social media company.

Follow Meta Platforms Inc. (NASDAQ:META)

Charter Communications, Inc. (NASDAQ:CHTR)

Charter Communications, Inc. (NASDAQ:CHTR) was in the portfolios of 134 of the funds tracked by Insider Monkey on June 30, significantly more than the 98 funds that held it a quarter earlier, thanks to its three-way merger with Time Warner Cable and Bright House coming to fruition. Stewart Strawbridge’s Selkirk Management owns 50,000 shares of the bolstered company as of June 30.

Follow Charter Communications Inc. (NASDAQ:CHTR)

Amazon.com, Inc. (NASDAQ:AMZN)

At the end of the third quarter, Ken Fisher’s Fisher Asset Management owned 1.97 million shares of Amazon.com, Inc. (NASDAQ:AMZN). Overall, as of the end of the second quarter, 145 funds in our database were bullish on Amazon.com, Inc. (NASDAQ:AMZN), ranking it just behind Facebook.

Follow Amazon Com Inc (NASDAQ:AMZN)

Allergan plc Ordinary Shares (NYSE:AGN)

A total of 131 funds tracked by us had $13.9 billion worth of Allergan plc Ordinary Shares (NYSE:AGN) shares in their portfolios as of the end of the second quarter. Andy Redleaf’s Whitebox Advisors reported having ownership of 48,699 shares of the company as of the end of the third quarter.

Follow Allergan Plc (NYSE:AGN)

Disclosure: None

Page 2 of 2